Click Here for 5% Off Your First Aladdin Purchase!

norendoxifen , CAS No.N612359, Inhibitor of CYP19A1;Antagonist of Estrogen receptor-α;Agonist of Estrogen receptor-β

  • Moligand™
Item Number
N612359
Grouped product items
SKUSizeAvailabilityPrice Qty
N612359-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$390.90
N612359-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,100.90

Basic Description

SynonymsNorendoxifen|Z-Norendoxifen|51GJD354B5|UNII-51GJD354B5|CHEMBL2386284|1308808-22-1|(E/Z)-N,N-Didesmethyl-4-hydroxy Tamoxifen|4-((1Z)-1-(4-(2-Aminoethoxy)phenyl)-2-phenyl-1-buten-1-yl)phenol|Phenol, 4-((1Z)-1-(4-(2-aminoethoxy)phenyl)-2-phenyl-1-buten-1-yl)
GradeMoligand™
Action TypeAGONIST, ANTAGONIST, INHIBITOR
Mechanism of actionInhibitor of CYP19A1;Antagonist of Estrogen receptor-α;Agonist of Estrogen receptor-β

Associated Targets

ESR1 Tclin Estrogen receptor 3 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ESR2 Tclin Estrogen receptor beta 3 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP19A1 Tclin Aromatase 3 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name 4-[(~{Z})-1-[4-(2-aminoethoxy)phenyl]-2-phenylbut-1-enyl]phenol
INCHI InChI=1S/C24H25NO2/c1-2-23(18-6-4-3-5-7-18)24(19-8-12-21(26)13-9-19)20-10-14-22(15-11-20)27-17-16-25/h3-15,26H,2,16-17,25H2,1H3/b24-23-
InChi Key YCQBLTPGQSYLHD-VHXPQNKSSA-N
Canonical SMILES NCCOc1ccc(cc1)/C(=C(\c1ccccc1)/CC)/c1ccc(cc1)O
Isomeric SMILES CC/C(=C(\C1=CC=C(C=C1)O)/C2=CC=C(C=C2)OCCN)/C3=CC=CC=C3
PubChem CID 68037237

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Lu WJ, Xu C, Pei Z, Mayhoub AS, Cushman M, Flockhart DA.  (2012)  The tamoxifen metabolite norendoxifen is a potent and selective inhibitor of aromatase (CYP19) and a potential lead compound for novel therapeutic agents..  Breast Cancer Res Treat,  133  (1): (99-109).  [PMID:21814747]
2. Lv W, Liu J, Lu D, Flockhart DA, Cushman M.  (2013)  Synthesis of mixed (E,Z)-, (E)-, and (Z)-norendoxifen with dual aromatase inhibitory and estrogen receptor modulatory activities..  J Med Chem,  56  (11): (4611-8).  [PMID:23731360]

Solution Calculators